SUMMIT
2026

OCTOBER 26-28, 2026 | NASHVILLE, TN

AN ACTION-ORIENTED SUMMIT ON THE DATA AND DIGITAL INFRASTRUCTURE NEEDED TO ENABLE PRECISION MEDICINE AT SCALE

Formerly the Genetic Health Information Network Summit

A ONE-OF-A-KIND, COLLABORATIVE FORUM OF INFLUENTIAL LEADERS

The only multi-stakeholder gathering focused on the data, digital infrastructure, and economic challenges facing precision medicine. A forum that includes:

  • Full spectrum of stakeholders: health care, policy, technology, science & patients

  • Collaborative, discussion-oriented format

  • Chatham-house rules — non-attribution

  • No sponsored talks, sales pitches or marketing lists

  • Published conference summary and recommendations

A Gathering of Committed Leaders From Across the Entire Health Care Ecosystem

Health Plans | Clinicians | Hospital Systems | Researchers | Policy Makers | Laboratories | Patients & Advocates | IT Vendors | Pharma

2026 ORGANIZING COMMITTEE

  • JOANNE ARMSTRONG, MD, MPH

    Chief Medical Officer & VP, Women’s Health & Genomics
    CVS Health

  • MARA ASPINALL

    Partner
    Illumina Ventures

  • NATASHA BONHOMME

    Founder
    Expecting Health

  • CARLOS BUSTAMANTE, PhD

    Founder & CEO
    Galatea Bio, Inc.

  • PETER DEVAULT

    VP, Interoperability & Genomics
    Epic

  • JOHN FOX, MD, MHA

    Senior Medical Director for the Americas, Market Access
    Illumina, Inc.

  • JILL HAGENKORD, MD

    National Medical Director of Molecular Pathology and Genomics
    UnitedHealthcare

  • CORA HAN, JD

    Chief Health Data Officer
    University of California Health

  • GILLIAN HOOKER, PhD, ScM, CGC

    Chief Scientific Officer
    Concert

  • STEVE KEILES, MS, CGC

    General Manager and Executive Director, US Specialty Genetics and Genomics Services
    Quest Diagnostics

  • DEVEN MCGRAW, JD, MPH

    Chief Regulatory & Privacy Officer
    Citizen Health

  • SAMYUKTA MULLANGI, MD

    Vice President of Clinical Strategy
    OpenEvidence

  • DEBORAH ONDRASIK, MD

    General Pediatrician
    Southcoast Physicians Group

View the 2025 Agenda

2025 SPEAKERS

  • FRANK HARVEY

    CEO
    Surescripts

  • MARA ASPINALL

    Partner
    Illumina Ventures

  • EZRA COHEN, MD

    CMO, Oncology
    Tempus

  • KATHERINE STUELAND

    CEO
    GeneDx

  • NAVNEET MAJHAIL, MD

    Physician-in-Chief of Blood Cancers
    Sarah Cannon Cancer Network

  • TOM GRAF, MD

    CMO, Medicare
    Florida Blue

  • SAMYUKTA MULLANGI, MD

    Senior Medical Director
    Thyme Care

  • JIM ALMAS, MD

    VP & National Medical Director, Clinical Effectiveness
    LabCorp

  • ARI AKERSTEIN, MS

    Co-Founder & CEO
    NavisAI & CancerHacker Lab

  • Emily Evans

    Managing Director
    Hedgeye Risk Management, LLC

  • MARK GINGRICH

    Chief Information Officer
    Surescripts

  • LEAH TIMMERMAN

    SVP, Health Plans
    Quest Diagnostics

  • DOUGLAS HOEY, Pharmacist

    CEO
    National Community Pharmacists Association

  • ELISSA LEVIN, MS, CGC

    Head, Medical Affairs
    Oxford Nanopore Technologies

  • KEVIN HUTCHINSON

    Senior Advisor
    Arsenal Capital Partners

  • RUSS PAULSEN

    COO
    USAgainstAlzheimer's

  • ASHLEY HUME

    President
    Emerging Therapy Solutions

  • RICK RATLIFF

    CEO
    MedAdvisor Solutions

  • MICHAEL S SHERMAN, MD

    Principal
    Sherman Healthcare Solutions, LLC

  • HANNAH MAMUSZKA, MS

    CEO
    Alva10

  • JAMES P. BRADLEY, MS

    Board Chairman
    Self Employed

  • COURTNEY LIAS, PhD

    Director, Office of In Vitro Diagnostics
    FDA

    No longer able to attend

  • CLIFF GOODMAN, PhD

    Moderator
    Independent

PAST SPEAKERS

  • FRANCIS COLLINS, MD, PhD

    Acting Science Advisor to the President of the United States

  • CARLOS BUSTAMONTE, PhD

    Founder & CEO
    Galatea Bio, Inc

  • TRENT HAYWOOD, MD, JD

    SVP & Chief Medical Officer
    Blue Cross Blue Shield Association

  • DEE ANNA SMITH

    CEO
    Sarah Cannon

VIEW ALL

Identify and resolve practical barriers facing precision medicine by

  • Improving the capture of clinical effectiveness and economic value data

  • Simplifying the test ordering and resulting workflow for clinicians, hospitals and labs

  • Streamlining the genetic test billing, adjudication and payment process

  • Reducing the frequency of misordered tests and surprise bills for patients

  • Empowering patients to harness the insights in their genetic makeup for greater health

BACK BY POPULAR DEMAND

The 2024 Summit is back, Driven by Last Year’s Enthusiastic Response and a +88 Net Promoter Score.

Accommodations will be at the Kimpton Aertson, a boutique hotel in Nashville.

1-45759737.jpg
8-58d5d279.jpg
lobby_01-1ca84636.jpg
20-90a1ef69.jpg
joliet-aertson-final-6803-62a5d348.jpg
15-38ad71d2.jpg
joliet-aertson-final-6564_king-corner-balcony-5da74045.jpg
woodlea-terrace-01-99ab6996.jpg
11-5fac915c.jpg

  • “Intimate engagement with key stakeholders in the genomic medicine space that does not otherwise happen all that often…Excellent and efficient organization and moderation with summary of key points throughout.”

    Director, Molecular Pathology

  • “Excellent speakers, panels, participants, and facilitation on relevant topics”

    CEO, genomics company

  • “It was a unique and diverse group of stakeholders with (most importantly) time to interact with each other. Key gaps that need to be bridged were openly discussed and at least understood, if not resolved.”

    Chief Medical Officer

  • “I thought that the summit raised important issues and brought together interested and diverse individuals to exchange ideas and propose serious solutions to real problems in the field.”

    President, advocacy organization

  • “Open discussion, and a focus on actionable takeaways. Attendance by people who are influential.”

    Director, Science Policy

Nominate someone.

This event is by invitation only. If you would like to nominate somebody, including yourself, to participate in the summit, please complete the following form:

Nominate